Annual D&A
$169.00 K
+$34.00 K+25.19%
01 December 2023
Summary:
COSCIENS Biopharma annual depreciation & amortization is currently $169.00 thousand, with the most recent change of +$34.00 thousand (+25.19%) on 01 December 2023. During the last 3 years, it has risen by +$24.00 thousand (+16.55%).CSCI Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$479.00 K
+$101.50 K+26.89%
01 September 2024
Summary:
COSCIENS Biopharma quarterly depreciation & amortization is currently $479.00 thousand, with the most recent change of +$101.50 thousand (+26.89%) on 01 September 2024. Over the past year, it has increased by +$95.50 thousand (+24.90%).CSCI Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$1.60 M
+$116.00 K+7.82%
01 September 2024
Summary:
COSCIENS Biopharma TTM depreciation & amortization is currently $1.60 million, with the most recent change of +$116.00 thousand (+7.82%) on 01 September 2024. Over the past year, it has increased by +$131.00 thousand (+8.93%).CSCI TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSCI Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +24.9% | +8.9% |
| 3 y3 years | +16.6% | +29.1% | +8.4% |
| 5 y5 years | -46.4% | +30.3% | +14.0% |
CSCI Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -98.4% | -28.4% | at high |
COSCIENS Biopharma Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $479.00 K(+26.9%) | $1.60 M(+7.8%) |
| June 2024 | - | $377.50 K(+5.3%) | $1.48 M(+1.0%) |
| Mar 2024 | - | $358.50 K(-6.5%) | $1.47 M(-0.0%) |
| Dec 2023 | $169.00 K(+25.2%) | $383.50 K(+5.6%) | $1.47 M(+0.7%) |
| Sept 2023 | - | $363.00 K(+0.2%) | $1.46 M(+4.1%) |
| June 2023 | - | $362.20 K(+0.9%) | $1.40 M(+0.3%) |
| Mar 2023 | - | $358.80 K(-3.9%) | $1.40 M(-0.8%) |
| Dec 2022 | $135.00 K(-6.9%) | $373.30 K(+22.0%) | $1.41 M(+0.2%) |
| Sept 2022 | - | $306.10 K(-14.6%) | $1.41 M(-2.9%) |
| June 2022 | - | $358.50 K(-3.2%) | $1.45 M(-1.8%) |
| Mar 2022 | - | $370.40 K(-0.1%) | $1.47 M(-0.0%) |
| Dec 2021 | $145.00 K(-37.5%) | $370.90 K(+6.5%) | $1.48 M(-2.6%) |
| Sept 2021 | - | $348.20 K(-9.6%) | $1.51 M(-0.7%) |
| June 2021 | - | $385.10 K(+3.8%) | $1.53 M(+2.4%) |
| Mar 2021 | - | $370.90 K(-9.7%) | $1.49 M(+3.2%) |
| Dec 2020 | $232.00 K(-26.3%) | $410.70 K(+14.4%) | $1.44 M(+3.1%) |
| Sept 2020 | - | $359.10 K(+2.7%) | $1.40 M(+1.4%) |
| June 2020 | - | $349.60 K(+7.8%) | $1.38 M(-0.3%) |
| Mar 2020 | - | $324.40 K(-11.8%) | $1.39 M(-1.2%) |
| Dec 2019 | $315.00 K(+443.1%) | $367.60 K(+8.3%) | $1.40 M(+9.3%) |
| Sept 2019 | - | $339.40 K(-4.0%) | $1.28 M(+27.5%) |
| June 2019 | - | $353.60 K(+3.5%) | $1.01 M(+42.2%) |
| Mar 2019 | - | $341.70 K(+37.5%) | $708.00 K(+66.7%) |
| Dec 2018 | $58.00 K(-38.3%) | $248.50 K(+296.3%) | $424.80 K(+89.1%) |
| Sept 2018 | - | $62.70 K(+13.8%) | $224.60 K(-5.9%) |
| June 2018 | - | $55.10 K(-5.8%) | $238.70 K(-4.9%) |
| Mar 2018 | - | $58.50 K(+21.1%) | $250.90 K(-3.2%) |
| Dec 2017 | $94.00 K(-66.4%) | $48.30 K(-37.1%) | $259.30 K(-0.3%) |
| Sept 2017 | - | $76.80 K(+14.1%) | $260.20 K(+2.4%) |
| June 2017 | - | $67.30 K(+0.6%) | $254.20 K(-3.0%) |
| Mar 2017 | - | $66.90 K(+36.0%) | $262.10 K(-2.0%) |
| Dec 2016 | $280.00 K(-17.9%) | $49.20 K(-30.5%) | $267.40 K(-4.7%) |
| Sept 2016 | - | $70.80 K(-5.9%) | $280.50 K(+3.5%) |
| June 2016 | - | $75.20 K(+4.2%) | $271.00 K(-2.0%) |
| Mar 2016 | - | $72.20 K(+15.9%) | $276.40 K(-2.2%) |
| Dec 2015 | $341.00 K(-61.2%) | $62.30 K(+1.6%) | $282.70 K(-2.2%) |
| Sept 2015 | - | $61.30 K(-23.9%) | $289.00 K(+1.5%) |
| June 2015 | - | $80.60 K(+2.7%) | $284.70 K(+7.1%) |
| Mar 2015 | - | $78.50 K(+14.4%) | $265.90 K(+4.2%) |
| Dec 2014 | $878.00 K(-7.5%) | $68.60 K(+20.4%) | $255.30 K(+5.3%) |
| Sept 2014 | - | $57.00 K(-7.8%) | $242.50 K(-6.6%) |
| June 2014 | - | $61.80 K(-9.0%) | $259.70 K(-3.1%) |
| Mar 2014 | - | $67.90 K(+21.7%) | $267.90 K(-2.5%) |
| Dec 2013 | $949.00 K(-23.1%) | $55.80 K(-24.8%) | $274.80 K(-8.1%) |
| Sept 2013 | - | $74.20 K(+6.0%) | $299.00 K(-0.4%) |
| June 2013 | - | $70.00 K(-6.4%) | $300.30 K(+0.9%) |
| Mar 2013 | - | $74.80 K(-6.5%) | $297.60 K(+1.2%) |
| Dec 2012 | $1.23 M(-27.0%) | $80.00 K(+6.0%) | $294.00 K(+0.2%) |
| Sept 2012 | - | $75.50 K(+12.2%) | $293.30 K(+5.4%) |
| June 2012 | - | $67.30 K(-5.5%) | $278.30 K(-3.1%) |
| Mar 2012 | - | $71.20 K(-10.2%) | $287.10 K(-1.4%) |
| Dec 2011 | $1.69 M | $79.30 K(+31.1%) | $291.20 K(+14.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2011 | - | $60.50 K(-20.5%) | $253.50 K(-11.0%) |
| June 2011 | - | $76.10 K(+1.1%) | $284.80 K(+2.2%) |
| Mar 2011 | - | $75.30 K(+81.0%) | $278.70 K(-4.1%) |
| Dec 2010 | $1.57 M(-85.5%) | $41.60 K(-54.7%) | $290.60 K(-13.9%) |
| Sept 2010 | - | $91.80 K(+31.1%) | $337.40 K(-2.0%) |
| June 2010 | - | $70.00 K(-19.7%) | $344.20 K(-3.9%) |
| Mar 2010 | - | $87.20 K(-1.4%) | $358.20 K(+5.1%) |
| Dec 2009 | $10.84 M(+51.5%) | $88.40 K(-10.3%) | $340.90 K(+15.8%) |
| Sept 2009 | - | $98.60 K(+17.4%) | $294.30 K(+8.9%) |
| June 2009 | - | $84.00 K(+20.2%) | $270.20 K(-0.5%) |
| Mar 2009 | - | $69.90 K(+67.2%) | $271.50 K(-1.8%) |
| Dec 2008 | $7.15 M(+28.5%) | $41.80 K(-43.9%) | $276.50 K(+7.5%) |
| Sept 2008 | - | $74.50 K(-12.7%) | $257.30 K(+16.4%) |
| June 2008 | - | $85.30 K(+13.9%) | $221.00 K(+31.0%) |
| Mar 2008 | - | $74.90 K(+231.4%) | $168.70 K(+38.6%) |
| Dec 2007 | $5.57 M(-41.0%) | $22.60 K(-40.8%) | $121.70 K(-4.5%) |
| Sept 2007 | - | $38.20 K(+15.8%) | $127.50 K(+4.3%) |
| June 2007 | - | $33.00 K(+18.3%) | $122.20 K(-0.7%) |
| Mar 2007 | - | $27.90 K(-1.8%) | $123.10 K(-2.2%) |
| Dec 2006 | $9.43 M(+48.0%) | $28.40 K(-13.7%) | $125.90 K(-5.8%) |
| Sept 2006 | - | $32.90 K(-2.9%) | $133.70 K(-4.1%) |
| June 2006 | - | $33.90 K(+10.4%) | $139.40 K(+1.2%) |
| Mar 2006 | - | $30.70 K(-15.2%) | $137.70 K(-1.1%) |
| Dec 2005 | $6.37 M(+3.8%) | $36.20 K(-6.2%) | $139.20 K(+7.1%) |
| Sept 2005 | - | $38.60 K(+19.9%) | $130.00 K(+17.0%) |
| June 2005 | - | $32.20 K(0.0%) | $111.10 K(+18.1%) |
| Mar 2005 | - | $32.20 K(+19.3%) | $94.10 K(+23.0%) |
| Dec 2004 | $6.14 M(-8.1%) | $27.00 K(+37.1%) | $76.50 K(+13.3%) |
| Sept 2004 | - | $19.70 K(+29.6%) | $67.50 K(+6.8%) |
| June 2004 | - | $15.20 K(+4.1%) | $63.20 K(+11.3%) |
| Mar 2004 | - | $14.60 K(-18.9%) | $56.80 K(+22.7%) |
| Dec 2003 | $6.68 M(+334.3%) | $18.00 K(+16.9%) | $46.30 K(+44.7%) |
| Sept 2003 | - | $15.40 K(+75.0%) | $32.00 K(+60.0%) |
| June 2003 | - | $8800.00(+114.6%) | $20.00 K(+29.9%) |
| Mar 2003 | - | $4100.00(+10.8%) | $15.40 K(+3.4%) |
| Dec 2002 | $1.54 M(+32.3%) | $3700.00(+8.8%) | $14.90 K(+0.7%) |
| Sept 2002 | - | $3400.00(-19.0%) | $14.80 K(-1.3%) |
| June 2002 | - | $4200.00(+16.7%) | $15.00 K(0.0%) |
| Mar 2002 | - | $3600.00(0.0%) | $15.00 K(-2.0%) |
| Dec 2001 | $1.16 M(+19.9%) | $3600.00(0.0%) | $15.30 K(-0.6%) |
| Sept 2001 | - | $3600.00(-14.3%) | $15.40 K(-42.3%) |
| June 2001 | - | $4200.00(+7.7%) | $26.70 K(+18.7%) |
| Mar 2001 | - | $3900.00(+5.4%) | $22.50 K(+21.0%) |
| Dec 2000 | $969.10 K(+36.6%) | $3700.00(-75.2%) | $18.60 K(+24.8%) |
| Sept 2000 | - | $14.90 K(-3080.0%) | $14.90 K(-77.1%) |
| Dec 1999 | $709.20 K(+118.2%) | - | - |
| Dec 1998 | $325.00 K(+132.5%) | -$500.00(-100.8%) | $65.00 K(-91.1%) |
| Sept 1998 | - | $65.50 K(-90.2%) | $734.20 K(-52.2%) |
| Dec 1997 | $139.80 K(-4.2%) | $668.70 K(+131.2%) | $1.54 M(+77.0%) |
| Sept 1997 | - | $289.20 K(-0.1%) | $868.70 K(+49.9%) |
| June 1997 | - | $289.60 K(-0.1%) | $579.50 K(+99.9%) |
| Mar 1997 | - | $289.90 K | $289.90 K |
| Dec 1996 | $145.90 K | - | - |
FAQ
- What is COSCIENS Biopharma annual depreciation & amortization?
- What is the all time high annual D&A for COSCIENS Biopharma?
- What is COSCIENS Biopharma quarterly depreciation & amortization?
- What is the all time high quarterly D&A for COSCIENS Biopharma?
- What is COSCIENS Biopharma quarterly D&A year-on-year change?
- What is COSCIENS Biopharma TTM depreciation & amortization?
- What is the all time high TTM D&A for COSCIENS Biopharma?
- What is COSCIENS Biopharma TTM D&A year-on-year change?
What is COSCIENS Biopharma annual depreciation & amortization?
The current annual D&A of CSCI is $169.00 K
What is the all time high annual D&A for COSCIENS Biopharma?
COSCIENS Biopharma all-time high annual depreciation & amortization is $10.84 M
What is COSCIENS Biopharma quarterly depreciation & amortization?
The current quarterly D&A of CSCI is $479.00 K
What is the all time high quarterly D&A for COSCIENS Biopharma?
COSCIENS Biopharma all-time high quarterly depreciation & amortization is $668.70 K
What is COSCIENS Biopharma quarterly D&A year-on-year change?
Over the past year, CSCI quarterly depreciation & amortization has changed by +$95.50 K (+24.90%)
What is COSCIENS Biopharma TTM depreciation & amortization?
The current TTM D&A of CSCI is $1.60 M
What is the all time high TTM D&A for COSCIENS Biopharma?
COSCIENS Biopharma all-time high TTM depreciation & amortization is $1.60 M
What is COSCIENS Biopharma TTM D&A year-on-year change?
Over the past year, CSCI TTM depreciation & amortization has changed by +$131.00 K (+8.93%)